Barnett Eva Renee

Chief Financial Officer

1 company

Good

Trades Analyzed

12M Win Rate

56.5%

Avg 3M Return

-1.8%

Avg 12M Return

-3.4%

Barnett Eva Renee is a Chief Financial Officer at Immunovant, Inc.. Recent SEC Form 4 filings include 0 buys and 14 sells.

Estimated insider holdings value: $11.5M based on current market prices.

Holdings by Company

IMVTApr 16, 2025

Current Shares396.8K

Value$11.48M

Net Activity-150,062

Bought: 0Sold: 150.1K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 9, 2024	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	4,747	$28.06	$133,200.82	-1.3%	-1.0%	-41.8%
May 22, 2024	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	4,042	$29.65	$119,845.30	-1.1%	+6.6%	-50.7%
Apr 17, 2024	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	12,253	$29.06	$356,048.76	-1.7%	+8.8%	-46.7%
Apr 9, 2024	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	3,689	$31.18	$115,023.02	-1.0%	-11.3%	-52.2%
Feb 22, 2024	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	2,930	$36.15	$105,919.50	-0.9%	-17.9%	-40.9%
Jan 11, 2024	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	3,515	$41.83	$147,023.46	-0.5%	-28.0%	-45.2%
Nov 22, 2023	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	4,055	$32.78	$132,919.83	-0.6%	+14.8%	-18.8%
Oct 10, 2023	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	4,557	$36.92	$168,244.44	-1.4%	+16.2%	-19.3%
Aug 24, 2023	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	14,386	$20.30	$292,036.39	-2.1%	+63.3%	+62.0%
Jul 19, 2023	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	2,725	$24.94	$67,961.50	-0.8%	+61.6%	+22.7%